Elelyso (taliglucerase alfa)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 ADVERSE REACTIONS Immunogenicity (updated paragraph) In a clinical trial of treatment-naïve pediatric patients, 2...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts